half yearly, gsk fim and strategic alliances, page-14

Good post from one of the greater posters on HC regarding EGO which is freely transferrable to our own situation here ( I equally just scratch my head wih astonishment ), quote:

Unfortunately many of the brokers I know are totally illiterate (something to do with evolution and genetic modification I am told) so they rely on being spoon fed: what will I research, and what should I tell my clients: which goes a long way in explaining why around 60% of the Financial Review is now devoted to pictures and diagrams [if you don't believe, do a column-inch count!]. I suggest, therefore, that anyone wanting to "spread the good word" take a viral view on this: call your broker tomorrow (no - you can't call Comsec or ETrade people!) and simply ask their thoughts on EGO. You would be surprised what effect this has: most brokers scratch their head, turn to "Macca" who sits beside them and ask the same question - sort of like a game of Chinese Whispers, except without using word of greater than one sylable...


I equally recommend to everybody to do their own research and anticipate what the market will only find out when it is too late to rake in the attractive gains.

Glyn is telling us as much as he can get away with and it won't get any clearer than this before the rerating event.